328 related articles for article (PubMed ID: 31603898)
1. Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP).
Timp JF; Braekkan SK; Lijfering WM; van Hylckama Vlieg A; Hansen JB; Rosendaal FR; le Cessie S; Cannegieter SC
PLoS Med; 2019 Oct; 16(10):e1002883. PubMed ID: 31603898
[TBL] [Abstract][Full Text] [Related]
2. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.
Nemeth B; van Adrichem RA; van Hylckama Vlieg A; Bucciarelli P; Martinelli I; Baglin T; Rosendaal FR; le Cessie S; Cannegieter SC
PLoS Med; 2015 Nov; 12(11):e1001899; discussion e1001899. PubMed ID: 26554832
[TBL] [Abstract][Full Text] [Related]
3. Risk prediction of recurrent venous thrombosis; where are we now and what can we add?
Timp JF; Lijfering WM; Rosendaal FR; le Cessie S; Cannegieter SC
J Thromb Haemost; 2019 Sep; 17(9):1527-1534. PubMed ID: 31188515
[TBL] [Abstract][Full Text] [Related]
4. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
[TBL] [Abstract][Full Text] [Related]
5. D-dimer at venous thrombosis diagnosis is associated with risk of recurrence.
Bjøri E; Johnsen HS; Hansen JB; Braekkan SK
J Thromb Haemost; 2017 May; 15(5):917-924. PubMed ID: 28166605
[TBL] [Abstract][Full Text] [Related]
6. Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: A randomized controlled trial.
Geersing GJ; Hendriksen JMT; Zuithoff NPA; Roes KC; Oudega R; Takada T; Schutgens REG; Moons KGM
PLoS Med; 2020 Jun; 17(6):e1003142. PubMed ID: 32589630
[TBL] [Abstract][Full Text] [Related]
7. External validation of the DASH prediction rule: a retrospective cohort study.
Tosetto A; Testa S; Martinelli I; Poli D; Cosmi B; Lodigiani C; Ageno W; De Stefano V; Falanga A; Nichele I; Paoletti O; Bucciarelli P; Antonucci E; Legnani C; Banfi E; Dentali F; Bartolomei F; Barcella L; Palareti G
J Thromb Haemost; 2017 Oct; 15(10):1963-1970. PubMed ID: 28762665
[TBL] [Abstract][Full Text] [Related]
8. Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation.
Ensor J; Riley RD; Jowett S; Monahan M; Snell KIe; Bayliss S; Moore D; Fitzmaurice D;
Health Technol Assess; 2016 Feb; 20(12):i-xxxiii, 1-190. PubMed ID: 26879848
[TBL] [Abstract][Full Text] [Related]
9. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow-up study.
Timp JF; Lijfering WM; Flinterman LE; van Hylckama Vlieg A; le Cessie S; Rosendaal FR; Cannegieter SC
J Thromb Haemost; 2015 Oct; 13(10):1823-32. PubMed ID: 26270389
[TBL] [Abstract][Full Text] [Related]
11. Lipid levels and risk of recurrent venous thrombosis: results from the MEGA follow-up study.
Morelli VM; Lijfering WM; Rosendaal FR; Cannegieter SC
J Thromb Haemost; 2017 Apr; 15(4):695-701. PubMed ID: 28135040
[TBL] [Abstract][Full Text] [Related]
12. Genetic variations associated with recurrent venous thrombosis.
van Hylckama Vlieg A; Flinterman LE; Bare LA; Cannegieter SC; Reitsma PH; Arellano AR; Tong CH; Devlin JJ; Rosendaal FR
Circ Cardiovasc Genet; 2014 Dec; 7(6):806-13. PubMed ID: 25210051
[TBL] [Abstract][Full Text] [Related]
13. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
[TBL] [Abstract][Full Text] [Related]
14. A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES).
Franco Moreno AI; García Navarro MJ; Ortiz Sánchez J; Martín Díaz RM; Madroñal Cerezo E; de Ancos Aracil CL; Cabello Clotet N; Perales Fraile I; Gimeno García S; Montero Hernández C; Zapatero Gaviria A; Ruiz Giardín JM
Eur J Intern Med; 2016 Apr; 29():59-64. PubMed ID: 26775136
[TBL] [Abstract][Full Text] [Related]
15. Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis.
Prandoni P; Vedovetto V; Ciammaichella M; Bucherini E; Corradini S; Enea I; Cosmi B; Mumoli N; Visonà A; Barillari G; Bova C; Quintavalla R; Zanatta N; Pedrini S; Villalta S; Camporese G; Testa S; Parisi R; Becattini C; Cuppini S; Pengo V; Palareti G;
Thromb Res; 2017 Jun; 154():35-41. PubMed ID: 28407492
[TBL] [Abstract][Full Text] [Related]
16. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.
Eichinger S; Heinze G; Jandeck LM; Kyrle PA
Circulation; 2010 Apr; 121(14):1630-6. PubMed ID: 20351233
[TBL] [Abstract][Full Text] [Related]
17. Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study.
Sokol J; Timp JF; le Cessie S; van Hylckama-Vlieg A; Rosendaal FR; Kubisz P; Cannegieter SC; Lijfering WM
J Thromb Haemost; 2018 Apr; 16(4):680-688. PubMed ID: 29377625
[TBL] [Abstract][Full Text] [Related]
18. Ten years of cerebral venous thrombosis: male gender and myeloproliferative neoplasm is associated with thrombotic recurrence in unprovoked events.
Lim HY; Ng C; Donnan G; Nandurkar H; Ho P
J Thromb Thrombolysis; 2016 Oct; 42(3):423-31. PubMed ID: 27085541
[TBL] [Abstract][Full Text] [Related]
19. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R
Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194
[TBL] [Abstract][Full Text] [Related]
20. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
